Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Cutaneous drug reactions
- Cutaneous Manifestations of Lupus Erythematosus
- Cutaneous Manifestations of Chronic Kidney Disease: A Narrative Review
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Lupus erythematosus: systemic and cutaneous manifestations
- Epithelial‐to‐mesenchymal transition in cutaneous wound healing: Where we are and where we are heading
- Cutaneous manifestations of systemic lupus erythematosus
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous and Ocular Late Complications of Sulfur Mustard in Iranian Veterans
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Regulatory roles of androgens in cutaneous wound healing
- Current management strategies for cutaneous T-cell lymphoma
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous wound healing: canine allogeneic ASC therapy
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Anticonvulsant-Induced Cutaneous Reactions
- Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Tumor Necrosis Factor in Sepsis
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Cutaneous Markers of Disorders Affecting Adult Horses
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Cutaneous Reactions to Drugs
- Mohs Surgery Report: An Approach to Cutaneous Surgical Defects of Forehead and Eyebrow Following Mohs Micrographic Surgery